| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 10, 100-106, Copyright © 1996 by Endocrine Society
ARTICLES |
Y Hayashi, D Mangoura and S Refetoff
Department of Medicine, University of Chicago, Illinois 60637, USA.
Resistance to thyroid hormone (RTH) is a dominantly inherited syndrome characterized by hyposensitivity to thyroid hormone caused by mutations in the thyroid hormone receptor-beta (TR beta) gene. Replication- defective recombinant adenoviruses were constructed that express the human wild-type (WT) TR beta, a human mutant TR beta identified in a family with RTH, and luciferase under the control of thyroid hormone (Luc). The efficient introduction and expression of these recombinant genes into adult mouse liver were confirmed by immunocytochemistry. Hypothyroid mice were infected with Luc alone and in combination with the WT TR beta or mutant TR beta. Half of the mice from each group were then treated with T3. Compared with mice infected with Luc alone, T3 treatment of mutant TR beta infected mice showed no changes in liver luciferase, weight, or 5'-deiodinase and spot 14 messenger RNA, and the decrease in the serum cholesterol concentration was blunted as in patients with RTH. The effects of T3 in mice infected with WT TR beta were comparable to those in mice infected with Luc alone. However, overexpression of the WT TR beta tended to further increase serum cholesterol in the hypothyroid state and decrease it in response to T3, suggesting that the unliganded TR has a constitutive effect in vivo and that higher TR levels can aggravate the manifestations of hypothyroidism and enhance the action of thyroid hormone. Transient somatic transfer of mutant TR genes provides a model for the study of RTH. It allows evaluation of the effect of genetic factors interacting with mutant TRs that modify the phenotype of RTH, without animal back- crossing.
This article has been cited by other articles:
![]() |
P. E. Macchia, P. Jiang, Y.-D. Yuan, R. A. S. Chandarardna, R. E. Weiss, O. Chassande, J. Samarut, S. Refetoff, and C. F. Burant RXR receptor agonist suppression of thyroid function: central effects in the absence of thyroid hormone receptor Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E326 - E331. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takeuchi, Y. Murata, P. Sadow, Y. Hayashi, H. Seo, J. Xu, B. W. O'Malley, R. E. Weiss, and S. Refetoff Steroid Receptor Coactivator-1 Deficiency Causes Variable Alterations in the Modulation of T3-Regulated Transcription of Genes in Vivo Endocrinology, April 1, 2002; 143(4): 1346 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Amma, A. Campos-Barros, Z. Wang, B. Vennström, and D. Forrest Distinct Tissue-Specific Roles for Thyroid Hormone Receptors {beta} and {{alpha}}1 in Regulation of Type 1 Deiodinase Expression Mol. Endocrinol., March 1, 2001; 15(3): 467 - 475. [Abstract] [Full Text] |
||||
![]() |
K. Hashimoto, F. H. Curty, P. P. Borges, C. E. Lee, E. D. Abel, J. K. Elmquist, R. N. Cohen, and F. E. Wondisford An unliganded thyroid hormone receptor causes severe neurological dysfunction PNAS, March 1, 2001; (2001) 51454698. [Abstract] [Full Text] |
||||
![]() |
P. E. Macchia, Y. Takeuchi, T. Kawai, K. Cua, K. Gauthier, O. Chassande, H. Seo, Y. Hayashi, J. Samarut, Y. Murata, et al. Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor alpha PNAS, December 14, 2000; (2000) 11306998. [Abstract] [Full Text] |
||||
![]() |
R. E. Weiss, Y. Murata, K. Cua, Y. Hayashi, H. Seo, and S. Refetoff Thyroid Hormone Action on Liver, Heart, and Energy Expenditure in Thyroid Hormone Receptor {beta}-Deficient Mice Endocrinology, December 1, 1998; 139(12): 4945 - 4952. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Bhat, C.-l. Yu, N. Yap, Q. Zhan, Y. Hayashi, P. Seth, and S.-y. Cheng Tumor Suppressor p53 Is a Negative Regulator in Thyroid Hormone Receptor Signaling Pathways J. Biol. Chem., November 14, 1997; 272(46): 28989 - 28993. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Weiss, D. Forrest, J. Pohlenz, K. Cua, T. Curran, and S. Refetoff Thyrotropin Regulation by Thyroid Hormone in Thyroid Hormone Receptor {beta}-Deficient Mice Endocrinology, September 1, 1997; 138(9): 3624 - 3629. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yagi, J. Pohlenz, Y. Hayashi, A. Sakurai, and S. Refetoff Resistance to Thyroid Hormone Caused by Two Mutant Thyroid Hormone Receptors {beta}, R243Q and R243W, with Marked Impairment of Function That Cannot Be Explained by Altered in Vitro 3,5,3'-Triiodothyroinine Binding Affinity J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1608 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Macchia, Y. Takeuchi, T. Kawai, K. Cua, K. Gauthier, O. Chassande, H. Seo, Y. Hayashi, J. Samarut, Y. Murata, et al. Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor alpha PNAS, January 2, 2001; 98(1): 349 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hashimoto, F. H. Curty, P. P. Borges, C. E. Lee, E. D. Abel, J. K. Elmquist, R. N. Cohen, and F. E. Wondisford An unliganded thyroid hormone receptor causes severe neurological dysfunction PNAS, March 27, 2001; 98(7): 3998 - 4003. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |